Journals / MN Kardiyoloji / 2021 / Cilt: 28 - Sayı: 3

Cardiac Imaging in Arrhythmogenic Cardiomyopathy

Aritmojenik Kardiyomiyopatide Kardiyak Görüntüleme

Pages
179–188
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this review, it is aimed to increase awareness about arrhythmogenic cardiomyopathy and the imaging modal‐ ities recommended by the guidelines that we can use in our daily practice in diagnosis will be discussed.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Arrhythmogenic cardiomyopathy; is one of the causes of sudden cardiac death at young ages.
📊
Key Findings & Data:Along with electrical changes, in the presence of any morphological or functional abnormality detected in the ventri‐ cles on imaging, the risk of ventricular arrhythmia and therefore sudden cardiac death increases.
💡
Conclusion & Impact:In this review, it is aimed to increase awareness about arrhythmogenic cardiomyopathy and the imaging modal‐ ities recommended by the guidelines that we can use in our daily practice in diagnosis will be discussed.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Arrhythmogenic cardiomyopathy; is one of the causes of sudden cardiac death at young ages. Secondary to the mutation in genes en‐ coding cardiac desmosomes, the myocardium is replaced by fat and fibrous tissue. Right ventricle is more common, but both ventricles can be affected. Along with electrical changes, in the presence of any morphological or functional abnormality detected in the ventri‐ cles on imaging, the risk of ventricular arrhythmia and therefore sudden cardiac death increases. In arrhythmogenic cardiomyopathy, exercise exacerbates the disease by revealing the phenotype. For this reason, it is possible to prevent sudden cardiac deaths with early precautions and recommendations taken after the early diagnosis of the disease. Cardiac imaging including electrocardiography, echocardiography and cardiac magnetic resonance imaging, as well as a good anamnesis, are non‐invasive methods recommended for diagnosis. Patients with arrhythmogenic cardiomyopathy and their family members should be evaluated clinically and by imaging meth‐ ods at the first visit and at regular intervals for the risk of developing ventricular arrhythmia, in terms of heart failure and the need for heart transplantation. In this review, it is aimed to increase awareness about arrhythmogenic cardiomyopathy and the imaging modal‐ ities recommended by the guidelines that we can use in our daily practice in diagnosis will be discussed.

Özet

Aritmojenik kardiyomiyopati; genç yaşta gelişen ani kardiyak ölüm sebeplerinden biridir. Kardiyak desmozomları kodlayan genlerdeki mutasyona sekonder olarak miyokardiyumun yağ ve fibröz doku ile yer değiştirmesi söz konusudur, sağ ventrikül daha sık olmakla bir‐ likte her iki ventrikül de etkilenebilmektedir. Elektriksel değişikliklerle birlikte, görüntülemede ventriküllerde saptanan herhangi bir mor‐ folojik veya fonksiyonel anormallik varlığında ventriküler aritmi ve dolayısıyla ani kardiyak ölüm riski artmaktadır. Aritmojenik kardiyo‐ miyopati de egzersiz fenotipi açığa çıkararak hastalığı alevlendirmektedir. Bu nedenle, aritmojenik kardiyomiyopati hastalarının erken tanınması ve dolayısıyla alınabilecek önlem ve önerilerle, gelişebilecek ani kardiyak ölümlerin önüne geçilebilmesi mümkündür. Alınan iyi bir anamnezin yanında, elektrokardiyografi, ekokardiyografi ve kardiyak manyetik rezonans görüntülemeyi içeren kardiyak görüntü‐ leme; tanıda kullanılması önerilen girişimsel olmayan yöntemlerdir. Aritmojenik kardiyomiyopati hastaları ve aile üyeleri; ventriküler aritmi riski, kalp yetersizliği ve kalp nakli gerekliliği açısından ilk vizitte ve düzenli aralıklarla klinik olarak ve görüntüleme yöntemleriy‐ le değerlendirilmelidir. Bu derlemede, aritmojenik kardiyomiyopati hakkında farkındalığın artırılması amaçlanmış olup, tanıda günlük pratiğimizde kullanabileceğimiz kılavuzların önerdiği görüntüleme yöntemleri tartışılacaktır.

🔖

Cite This Article

GÜNGÖREN, F., TANRIVERDİ, Z., TAŞCANOV, M. B., BİÇER, A., ALTIPARMAK, İ. H. (2022). Cardiac Imaging in Arrhythmogenic Cardiomyopathy. MN Kardiyoloji, Cilt: 28 - Sayı: 3, 179–188. https://ajindex.com/articles/581463

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Norman M. Simpson M. Mogensen J. et al. Novel mutation in desmoplakin causes arrhythmogenic left ventricular cardiomyopathy. Circulation. 2005;112(5):636­42
  2. Marcus FI. Edson S. Towbin JA. Genetics of arrhythmogenic right ventricular cardiomyopathy:a practical guide for physicians. J Am Coll Cardiol. 2013;61(9):1945­48
  3. Nava A. Bauce B. Basso C. et al. Clinical profile and longterm follow­up of 37 families with arrhythmogenic right ventricular cardiomyopathy. J Am Coll Cardiol. 2000;36(7): 2226­33
  4. Nava A. Thiene G. Canciani B. et al. Familial occurrence of right ventricular dysplasia: a study involving nine families. J Am Coll Cardiol. 1988;12(5):1222­8
  5. Basso C. Bauce B. Corrado D. Thiene G. Pathophysiology of arrhythmogenic cardiomyopathy. Nat Rev Cardiol. 2011;9(4):223­33
  6. Lindstrom L. Nylander E. Larsson H. Wranne B. Left ventricular involvement in arrhythmogenic right ventricular cardiomyopathy­a scintigraphic and echocardiographic study. Clin Physiol Funct Imaging. 2005;25(3):171­7
  7. McKenna WJ. Thiene G. Nava A. et al. Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology. Br Heart J. 1994;71(3):215­8
  8. Hamid MS. Norman M. Quraishi A. Firoozi S. Thaman R. Gimeno JR et al. Prospective evaluation of relatives for familial arrhythmogenic right ventricular cardiomyopathy/ dysplasia reveals a need to broaden diagnostic criteria. J Am Coll Cardiol. 2002;40(8):1445­50
  9. Cox MG. Nelen MR. Wilde AA. Wiesfeld AC. van der Smagt JJ. Loh P et al. Activation delay and VT parameters in arrhythmogenic right ventricular dysplasia/ cardiomyopathy: toward improvement of diagnostic ECG criteria. J Cardiovasc Electrophysiol. 2008;19(8):775­81
  10. Basso C. Thiene G. Corrado D. Angelini A. Nava A. Valente M. Arrhythmogenic right ventricular cardiomyopathy. Dysplasia. dystrophy. or myocarditis? Circulation. 1996; 94(5):983­91
  11. Marcus FI. McKenna WJ. Sherrill D. et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria. Eur Heart J. 2010;31(7):806­14
  12. Sen­Chowdhry S. Syrris P. Prasad SK. Hughes SE. Merrifield R. Ward D et al. Left­dominant arrhythmogenic cardiomyopathy: an under­recognized clinical entity. J Am Coll Cardiol. 2008;52(25):2175­87.